CompletedNCT03622749
Official study titlePilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders
This study has finished and is no longer accepting participants.
In CharlestownBipolarityDevice studyAges 18–55
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00221403
Official study titlePlacebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders
This study has finished and is no longer accepting participants.
Multiple locations, including CincinnatiBipolarityMedication studyAges 3–7
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT00226135
Official study titleLamotrigine Versus Lithium in Subjects With Bipolar Affective Disorders - a Randomised Study of Prophylactic Effect
This study has finished and is no longer accepting participants.
In RisskovBipolarityMedication studyAges 18+
- Countries
- Denmark
- Sponsor
- University of Aarhus
CompletedNCT00090311
What is this study about?This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including ScottsdaleBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- AstraZeneca
TerminatedNCT01677182
What is this study about?This study evaluates the safety and effectiveness of Ramelteon for people with bipolarity.
This study ended early.
Multiple locations, including BirminghamBipolarityMedication studyAges 18–75
- Countries
- United States, United Kingdom, Bulgaria, + 7 others
- Sponsor
- Takeda
TerminatedNCT03210480
Official study titleClinical Evaluation of Switching to Lithiofor® (Lithium Sulphate Slow -Release, Li-SR Tablets) From Carbolithium® (Lithium Carbonate Immediate-Release, Li-IR, Capsules) in Bipolar Patients, Poorly Tolerant to Lithium Immediate-release Treatment.
This study ended early.
Multiple locations, including OrbetelloBipolarityMedication studyAges 18–65
- Countries
- Italy
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
CompletedNCT00126009
What is this study about?This study evaluated the safety and effectiveness of Amisulpride for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including PragueBipolarityMedication studyAges 18–65
- Countries
- France, Czechia, Poland, + 2 others
- Sponsor
- Sanofi
CompletedNCT00097266
Official study titleA Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimBipolarityMedication studyAges 18+
- Countries
- United States, Bulgaria, Croatia, + 4 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
TerminatedNCT05161546
Official study titleStudy of Bipolar Disorders and Retinal Electrophysiological Markers
This study ended early.
In LaxouBipolarityDevice studyAges 18+
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
CompletedNCT00350857
What is this study about?This study evaluated the safety and effectiveness of Extended-Release Carbamazepine for people with bipolarity.
This study has finished and is no longer accepting participants.
Multiple locations, including Altamonte SpringsBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Validus Pharmaceuticals
CompletedEUCTR 2008-000281-23
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomBipolarityHistorical research recordAges 18–65
- Countries
- United Kingdom
- Sponsor
- University of Oxford (University)
CompletedEUCTR 2017-002225-38
Official study titleA Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects with Bipolar I Disorder
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaBipolarityHistorical research record
- Countries
- Bulgaria, Croatia, Poland
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)